Design, synthesis, and anticancer properties of 4,4′ -dihydroxybenzophenone-2,4-dinitrophenylhydrazone and analogues

Journal of Medicinal Chemistry

Volumn 46, Issue 21, 2003, Pages 4552-4563

  Morgan, Lee Roy ^a   Thangaraj, Kanappan ^a   LeBlanc, Blaise ^a   Rodgers, Andrew ^a   Wolford, Lionel T ^a   Hooper, Catherine L ^a   Fan, Dominic ^b   Jursic, Branko S ^c  

^a DEKK TEC Incorporated   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF NEW ORLEANS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 DINITROPHENOL; 4,4 DIHYDROXYBENZOPHENONE 2,4 DINITROPHENYLHYDRAZONE; 4,4' DIHYDROXYBENZOPHENONE 2,4 DINITROPHENYLHYDRAZONE; ANTINEOPLASTIC AGENT; BENZOPHENONE DERIVATIVE; HYDRAZONE DERIVATIVE; METHANE; PHENYLHYDRAZONE DERIVATIVE; QUINONE DERIVATIVE; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL LINE; DRUG CYTOTOXICITY; DRUG DESIGN; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; EXPLANT; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; REACTION ANALYSIS; SOLID TUMOR; STRUCTURE ANALYSIS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; CRYSTALLOGRAPHY, X-RAY; CULTURE TECHNIQUES; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDRAZONES; HYDROGEN BONDING; INDICATORS AND REAGENTS; MICE; PHENOLS; STEM CELLS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 0141958090     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0301080     Document Type: Article

References (23)

1. Eilender, D. E.; LoRusso, P.; Krementz, E. T.; Tornyos, K.; Thomas, L.; McCormick, C. Topical use of 4,4′ -dihydroxybenzophenone-2,4-dinitrophenylhydrazone (1) as a 0.25% gel in the treatment of malignant cutaneous metastases-a phase I study. In Proceedings of the 10th NCI-EORTC Symposium on New Drugs in Cancer Therapy, Amsterdam, The Netherlands, June 16-19, 1998; NCI-EORTC, 1998; Vol. 288, Abstract 477.
2. Eilender, D. E.; McCormick, C.; Tornyos, K. Recurrent CD30/KI-1-positive lymphomas of the skin treated with topical 4,4′ -dihydroxybenzophenone-2,4-dinitrophenylhydrazone (1) as a 0.25% gel. Proc. Am. Soc. Clin. Oncol. 1999, 18, 96.
3. Klein, C. L.; Gray, D.; Stevens, E. D. Crystal and molecular structures of benzophenone phenylhydrazone derivatives with anticancer activity. Struct. Chem. 1993, 4, 377-383.
4. Thangaraj, K.; Morgan, L. R. N-Alkylation of aromatic and heteroaromatic-2,4-dinitrophenyl-hydrazones with potassium fluoride on alumina. Synth. Commun. 1994, 24, 2063-2067.
5. Morgan, L. R.; Rodgers, A. H.; Fan, D.; Soike, K.; Ratterree, M.; Sartin, B. W.; Harrison, T. J. Comparative preclinical toxicology and pharmacology of 4,4′-dihydroxybenzophenone-2,4-dinitro-phenylhydrazone (1) in vitro and in rodents and primates. In Vivo 1997, 11, 29-38.
6. Morgan, L. R.; Gillen, L. E.; Hooper, C. L. Substituted benzophenone dinitrophenylhydrazones with antitumor activities in hormone dependent breast tumors. Breast Cancer Res. Treat. 1988, 12, 119-124.
7. Fan, D.; Morgan, L. R.; Earnest, L. E.; Seid, C. Superior in vitro antiproliferative activity of a novel dinitrophenylhydrazone derivative (1) against the MDA-MB-435 human breast carcinoma cells at equivalent myelotoxic concentrations. Breast Cancer Res. Treat. 1990, 16, 164.
8. Thangaraj, K.; Morgan, L. R.; Benes, E. N.; Jursic, B. S.; Fan, D. Aryl-2,4-dinitrophenylhydrazone activities in vitro against fresh human cancer cells. Breast Cancer Res. Treat. 1993, 27, 77.
9. Easmon, J.; Heinisch, G.; Purtinger, G.; Hofman, J. Synthetic and cyctotoxic evaluations of analogs of the antiestrogenic agent 4,4′-dihydroxybenzophenone-2,4-dinitrophenyhhydrazone (1). Proc. Am. Assoc. Cancer Res. 2000, 4, 656.
10. Morgan, L. R.; Thangaraj, K.; LeBlanc, B. W.; Rodgers, A. H.; Boue', S. M.; Cole, R. B. SAR for anticancer aryl/heterocyclic-2,4-dinitrophenylhydrazones. In Proceedings of Molecular Targets and Cancer Therapeutics; AACR/NCI/EORTC: Washington, DC, 1999; Abstract 406.
11. Morgan, L. R.; Jursic, B. S.; Hooper, C. L.; Neumann, D. M.; Thangaraj, K.; LeBlanc, B. Anticancer activity for 4,4′ -dihydroxybenzophenone-2,4-dinitrophenylhydrazone (1) analogues and their abilities to interact with lymphoendothelial cell surface markers. Bioorg. Med. Chem. Lett. 2002, 12, 3407-3411.
12. Golden, R.; Stock, L. M. Dissociation constants of 8-substituted 9,10-ethanolanthracene-1-carboxylic acids and related compounds. Evidence for the field model polar effect. J. Am. Chem. Soc. 1972, 94, 3080-3088.
13. Campbell, N.; McCullum, S. R.; MacKenzie, D. J. Reactivity of the carbonyl group in xanthones. J. Chem. Soc. 1957, 1922-1925.
14. Morgan, L. R. Methods to predict responses to therapy. U.S. Patent 5,270,172, 1993.
15. Alley, M. C.; Scudiero, D. A.; Monks, A.; Hursey, M. L.; Czerwinski, M. J.; Fune, D. L.; Abot, B. J.; Shoemaker, R. H.; Boyd, M. R. Feasibility of drug screening with panels of human cell lines using a microculture tetrazolium assay. Cancer Res. 1988, 48, 589-601.
16. Fan, D.; Morgan, L. R.; Schneider, C.; Blank, H.; Fan, S. Cooperative evaluation of human tumor chemosensitivity in the soft-agar assay and its clinical correlations. J. Cancer Res. Clin. Oncol. 1985, 109, 23-28.
17. Fan, D.; Morgan, L. R.; Schneider, C.; Blank, H.; Roy, S.; Wang, Y. F.; Fan, S. Pharmacologic assessment of regimen chemotherapy in the soft-agar assay: effect of oxygen on human tumors. J. Cancer Res. Clin. Oncol. 1985, 110, 209-215.
18. Greenberger, J. S.; Humphries, R. K.; Reid, D. M.; Messiner, H.; Sakaeeny, M. A. Molecularly cloned and expressed murine T-cell gene product with multipotential CSF properties is biologically similar to interleukin-3. Exp. Hematol. 1985, 13, 249-260.
19. Morgan, L. R.; Hooper, C. L.; Rodgers, A. Unpublished results.
20. Von Hoff, D. D.; Harris, G. J.; Johnson, G.; Glaubiger, D. Initial experience with human tumor stem cell assay system: potential and problems. In Cloning of Human Tumor Stem Cells; Salmon, S. E., Ed.; Alan R. Liss, Inc.: New York, 1980; pp 114-124.
21. Pullman, A.; Pullman, B. From quantum chemistry to quantum biochemistry. In Horizons in Biochemistry; Kasha, M., Pullman, B., Eds.; Academic Press: New York, 1966; pp 553-582.
22. Morgan, L. R.; Benes, E.; Fan, D. Use of 4,4′ -dihydroxyben-zophenone-2,4-dinitrophenylhydrazone as an indicator for systemic cancer therapies. J. Tumor Marker Oncol. 1992, 7, 90.
23. U.S. Pharmacopeia 24/Nation Formulary 29; U.S. Pharmacopea Convention: Rockville, MD, 2000; pp 1837-1847.